PP
KYNB

PDT Partners’s Kyntra Bio KYNB Stock Holding History

PDT Partners’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,891
Closed -$263K – 616
2023
Q2 		$263K Hold
3,891
– – 0.04% 475
2023
Q1 		$1.82M Buy
3,891
+1,516
+64% +$802K 0.25% 138
2022
Q4 		$951K Sell
2,375
-414
-15% -$159K 0.15% 236
2022
Q3 		$907K Sell
2,789
-4,087
-59% -$1.32M 0.14% 250
2022
Q2 		$1.81M Buy
6,876
+440
+7% +$112K 0.16% 198
2022
Q1 		$1.93M Buy
6,436
+3,786
+143% +$1.32M 0.17% 183
2021
Q4 		$934K Buy
+2,650
New +$825K 0.07% 378
2021
Q2 		– Sell
-679
Closed -$589K – 849
2021
Q1 		$589K Buy
+679
New +$723K 0.04% 474
2020
Q2 		– Sell
-1,043
Closed -$906K – 712
2020
Q1 		$906K Buy
+1,043
New +$1.04M 0.07% 241
2015
Q2 		– Sell
-412
Closed -$323K – 1421
2015
Q1 		$323K Buy
+412
New +$319K 0.01% 1136

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's KYNB Position: Q3 2023 in Review

PDT Partners sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 3,891 shares — an estimated $263K sold.

PDT Partners first reported a position in KYNB in Q1 2015 and held it in 10 quarters. The position peaked at $1.93M in Q1 2022. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • PDT Partners reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • PDT Partners sold 3,891 Kyntra Bio shares in Q3 2023, an estimated $263K.
  • PDT Partners first reported a position in Kyntra Bio in Q1 2015 and held it in 10 quarters.
  • PDT Partners's Kyntra Bio position peaked at $1.93M in Q1 2022.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on PDT Partners's 13F filing for Q3 2023, filed 14 Nov 2023.